• Home
  • About Us
    • Board of Directors
    • Board Committees
  • Products
    • Anti Biotics & Anti Infectives
    • Beta-lactams- Penicillins
    • Antifungals
    • Miscellaneous
    • Vitamins & Supplements
    • Cardiovasculars
    • Antipyretic, Analgesic, NSAIDs
    • Antacid, Anti-Ulcer Drugs
    • Antidepressants, Antipsychotics
    • Antimalarials
    • Dry Syrups
    • Ointments & Creams
    • Anti-Diabetics
    • Syrups
  • Investors Relation
    • General Meetings
    • Shareholding Pattern
    • Stock Exchange Intimation
    • Investor Complaints
    • Investor Relation Announcements
    • Attendence Sheet & Proxy Form
    • Annual Report
    • Financials Results
    • Unpaid / Unclaimed Dividend
    • Policies
    • Memorandum of Association (MOA) and Articles of Association (AOA)
    • Integrated Filing - Governance
  • Contact Us

Financial Report


pdf-30 Unaudited Quarterly Financial Results June, 2025

pdf-30 Unaudited Quarterly Financial Results September, 2025

pdf-30 Audited Financial Results March, 2025

pdf-30Unaudited Quarterly Financial Results December, 2024

pdf-30Unaudited Quarterly Financial Results September, 2024

pdf-30Unaudited Quarterly Financial Results June, 2024

pdf-30Audited Financial Results March 2024

pdf-30Unaudited Quarterly Financial Results December, 2023

pdf-30Unaudited Quarterly Financial Results September, 2023

pdf-30Unaudited Quarterly Financial Results June, 2023

pdf-30Audited Financial Results March 2023

pdf-30Audited Financial Results March 2022

pdf-30Unaudited Quarterly Financial Results December, 2022

pdf-30Investor Presentation September 2022

pdf-30Unaudited Quarterly Financial Results September 2022

pdf-30Unaudited Quarterly Financial Results June 2022

pdf-30 Unaudited Financial Results September 2021

pdf-30 Audited Financial Results March 2021

pdf-30 Unaudited Financial Results September 2020

pdf-30Financial Result_31st March 2020

pdf-30Financial Results 30th September 2019

pdf-30Financial Results 31st March 2019

pdf-30Financial Results 30th September 2018

pdf-30Financial Results 31st March 2018

pdf-30Intimation of acquisition of a new manufacturing unit at Palghar

pdf-30Signed Financials Medico Remedies-FY 16-17

pdf-30Balance Sheet as at 31'st March 2016

pdf-30Statement Of Profit And Loss For The Year Ended 31st March 2016

pdf-30Balance Sheet as at 31'st March 2015

pdf-30Statement Of Profit And Loss For The Year Ended 31st March 2015

pdf-30FY 13-14 Balance Sheet

pdf-30FY 12-13 -Balance Sheet


Our Company, Medico Remedies Limited, is a pharmaceutical formulation manufacturing company with manufacturing and marketing capabilities in formulation with focus on anti-infective, Beta-Lactums.

Contact info

  • Medico Remedies Limited
    Harshit Mehta(Director) 1105/1106, Hubtown Solaris, N.S.Phadke Marg, opp.teligali, Andheri East ,
    Mumbai-400069.
  • +91-22- 68943803
  • secretarialmrl@gmail.com

Link

  • About Us
  • Investor
  • Products
  • Contact Us

Connect With Us

©Copyright 2017 Medico Remedies Ltd : Design by :- Find Solution